KIMBERLY STUMP: Open Payments
NPI 1770129835 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 11 payments from 8 companies in 2025. Trend: 2023 $588 · 2024 $98 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| PFIZER INC. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| EVOKE PHARMA, INC. | 1 | $18 |
Products named: DUPIXENT, ENTYVIO, XIFAXAN, LINZESS, XELJANZ, REZDIFFRA, VEGZELMA, GIMOTI.
Industry payments across OH — which companies pay providers there.
